Related references
Note: Only part of the references are listed.Targeting Fibroblast Growth Factor Receptor 1 for Treatment of Soft-Tissue Sarcoma
Priya Chudasama et al.
CLINICAL CANCER RESEARCH (2017)
Cooperation of BRAFF595L and mutant HRAS in histiocytic sarcoma provides new insights into oncogenic BRAF signaling
M. Kordes et al.
LEUKEMIA (2016)
High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma
Aaron M. Udager et al.
CANCER RESEARCH (2015)
A mutational signature in gastric cancer suggests therapeutic strategies
Ludmil B. Alexandrov et al.
NATURE COMMUNICATIONS (2015)
SMARCB1 (INI-1)-deficient Carcinomas of the Sinonasal Tract
Justin A. Bishop et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms
Abbas Agaimy et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Molecular profiling of sinonasal undifferentiated carcinoma
Alexander Gelbard et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Stabilization of Disease after Targeted Therapy in a Thymic Carcinoma with KIT Mutation Detected by Clinical Next-Generation Sequencing
Ian S. Hagemann et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances
Jose Luis Llorente et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Molecular characterization of an Italian series of sporadic GISTs
P. Origone et al.
GASTRIC CANCER (2013)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri et al.
LANCET (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
NUT Midline Carcinomas of the Sinonasal Tract
Justin A. Bishop et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
KIT as a Therapeutic Target in Metastatic Melanoma
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Ken-Hong Lim et al.
BLOOD (2009)
Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas
I. Satzger et al.
BRITISH JOURNAL OF CANCER (2008)
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
Michael C. Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Signal transduction via the stem cell factor receptor/c-Kit
L Rönnstrand
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
MC Heinrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
